Repair of tissues or organs, characterized by a limited regenerative potential, is the major goal of cell therapy. Cardiac pathologies are among the leading causes of mortality and morbidity in industrialized countries, and current treatments are aimed at preserving the cardiac function compromised by the pathology rather than restoring the proper functions. The discovery of various stem/progenitor cells with different degrees of plasticity has opened the possibility to regenerate the lost myocardium and thus to improve cardiac function.
Stem cells can be classified as pluripotent or multipotent on the basis of their differentiation capacity. Although the ability of pluripotent stem cells to differentiate into cardiomyocytes is well established, 1 In view of a potential therapeutic application of adipocytederived DFAT cells, a possible drawback is their limited in vitro self-renewal capacity; indeed, after few passages, DFAT cells lose the ability to differentiate into cardiac myocytes. However, mature adipocytes do not represent a limited population in vivo and can indeed be isolated in great quantity directly from subcutaneous fat. For this reason, neither a high proliferative potential nor an extensive cellular amplification is necessary to ensure an adequate number of DFAT cells. Another important feature of DFAT cells is that they derive from a population of 99.9% pure adipocytes 9 ; the abundance, purity, and homogeneity of the starting cell population may be particularly important in order to avoid the chance that contaminating cell types overgrow and eventually differentiate towards undesired phenotypes. For example, this can be associated with the prolonged amplification in culture necessary to obtain an adequate number of adult stem cells which are scarcely represented in the tissue of origin. An intriguing hypothesis arising from the work of Jumabay et al. is that adipocytes and cardiomyocytes may be developmentally close and that DFAT cells may represent a common precursor to both lineages. Indeed, along with the evidence of spontaneous cardiac differentiation, this is indicated by the result that the cardiac differentiation of DFAT cells is increased by inhibition of the BMP or the Wnt pathways, a mechanism already reported to be important during both heart development 15 and cardiac differentiation of embryonic stem cells. 16 Recently, DFAT cells have also been derived from GFPtransgenic rats by the same group. 17 These cells can be induced to differentiate into cardiomyocytes in vitro by specific culture conditions (direct co-culture with neonatal cardiac myocytes or culture with neonatal cardiac myocytes-conditioned medium or culture in MethoCult) and in vivo by injection in the infarcted heart. In this case, beside surviving for several weeks, these rat DFAT cells also induced neoangiogenesis. Unfortunately, no analysis has been made of functional/electrical properties of in vitro/in vivo DFAT-derived cardiomyocytes, nor has any improvement in cardiac function been demonstrated. Because of their abundance, easy isolation procedure, little in vitro processing, and high yield of spontaneous differentiation, subcutaneous white adipocyte-derived DFAT cells appear be more suitable to autologous cardiac regeneration than the most commonly used progenitor/stem cells. Nonetheless, further research is needed to better characterize this cellular substrate, and some caution is necessary until human DFAT cells can be shown to possess all the molecular and functional properties that will make them a selectable source of exogenous myocytes for heart repair.
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